Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,827 | 144 | 96.9% |
| Unspecified | $150.00 | 1 | 2.1% |
| Education | $65.00 | 2 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,194 | 60 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $666.56 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $585.86 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $487.01 | 15 | $0 (2019) |
| Novo Nordisk Inc | $482.11 | 13 | $0 (2021) |
| Lilly USA, LLC | $444.25 | 7 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $258.79 | 3 | $0 (2018) |
| Amgen Inc. | $216.67 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $202.23 | 3 | $0 (2018) |
| Indivior Inc. | $150.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $250.01 | 9 | GlaxoSmithKline, LLC. ($139.57) |
| 2020 | $729.65 | 23 | AstraZeneca Pharmaceuticals LP ($322.79) |
| 2019 | $1,522 | 30 | AstraZeneca Pharmaceuticals LP ($916.16) |
| 2018 | $1,695 | 37 | AstraZeneca Pharmaceuticals LP ($639.82) |
| 2017 | $2,846 | 48 | Teva Pharmaceuticals USA, Inc. ($666.56) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/02/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: PRIMARY CARE | ||||||
| 08/28/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.09 | General |
| 07/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.35 | General |
| 02/11/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: PRIMARY CARE | ||||||
| 01/28/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.18 | General |
| 12/23/2020 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2020 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: PRIMARY CARE | ||||||
| 11/24/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2020 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Diabetes | ||||||
| 10/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Neurology | ||||||
| 10/08/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2020 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 08/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information | Indivior Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 150 | 298 | $28,332 | $17,038 |
| 2020 | 10 | 315 | 509 | $36,711 | $17,501 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 179 | $25,955 | $15,749 | 60.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $1,365 | $756.10 | 55.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 21 | 30 | $600.00 | $291.30 | 48.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 23 | 49 | $196.00 | $160.72 | 82.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 27 | $216.00 | $81.00 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 166 | $23,860 | $12,467 | 52.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 53 | $5,370 | $2,035 | 37.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 29 | 29 | $1,015 | $554.24 | 54.6% |
| 82274 | Stool analysis for blood | Office | 2020 | 32 | 34 | $850.00 | $538.08 | 63.3% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2020 | 15 | 15 | $2,700 | $458.19 | 17.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 24 | 47 | $940.00 | $444.19 | 47.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 21 | $525.00 | $358.13 | 68.2% |
| 97032 | Application of electrical stimulation to 1 or more areas, each 15 minutes | Office | 2020 | 15 | 27 | $783.00 | $284.67 | 36.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 25 | 67 | $268.00 | $215.15 | 80.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 40 | 50 | $400.00 | $146.13 | 36.5% |
About Dr. Vincent Granowicz, DO
Dr. Vincent Granowicz, DO is a Family Medicine healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528057270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Granowicz, DO has received a total of $7,042 in payments from pharmaceutical and medical device companies, with $250.01 received in 2021. These payments were reported across 147 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,827).
As a Medicare-enrolled provider, Granowicz has provided services to 465 Medicare beneficiaries, totaling 807 services with total Medicare billing of $34,539. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Royal Oak, MI
- Active Since 10/17/2005
- Last Updated 10/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528057270
Products in Payments
- FARXIGA (Drug) $2,053
- COPAXONE (Drug) $666.56
- JARDIANCE (Drug) $462.93
- BELSOMRA (Drug) $334.22
- INVOKANA (Drug) $233.60
- Tresiba (Drug) $208.45
- TRULICITY (Drug) $193.22
- BUPRENORPHINE AND NALOXONE (Drug) $150.00
- TRELEGY ELLIPTA (Drug) $139.57
- VYVANSE (Drug) $137.78
- BASAGLAR (Drug) $135.38
- BYDUREON (Drug) $124.86
- BELBUCA (Drug) $123.00
- Repatha (Biological) $122.70
- Xultophy 100/3.6 (Drug) $121.84
- TOUJEO (Drug) $110.17
- PRALUENT ALIROCUMAB INJECTION (Biological) $107.25
- ImmunoCAP (Device) $98.52
- ENTRESTO (Drug) $97.67
- PRESTIGE (Device) $96.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Royal Oak
Dr. Kristopher Patnugot, D.o, D.O
Family Medicine — Payments: $5,252
Dr. Julie Mariotti, Md, MD
Family Medicine — Payments: $2,393
Dr. Bethany Leighton, D.o, D.O
Family Medicine — Payments: $2,053
Dr. Tiffany Marchewka, Do, DO
Family Medicine — Payments: $1,928
Helen Ostro-Brown, M.d, M.D
Family Medicine — Payments: $1,421
Paul Ehrmann, D.o, D.O
Family Medicine — Payments: $886.75